scholarly journals Application of Phi29 Motor pRNA for Targeted Therapeutic Delivery of siRNA Silencing Metallothionein-IIA and Survivin in Ovarian Cancers

2011 ◽  
Vol 19 (2) ◽  
pp. 386-394 ◽  
Author(s):  
Pheruza Tarapore ◽  
Yi Shu ◽  
Peixuan Guo ◽  
Shuk-Mei Ho
2012 ◽  
Vol 9 (10) ◽  
pp. 2863-2874 ◽  
Author(s):  
Xi-Qiu Liu ◽  
Meng-Hua Xiong ◽  
Xiao-Ting Shu ◽  
Rui-Zhi Tang ◽  
Jun Wang

2015 ◽  
Vol 7 (5) ◽  
pp. 253-265 ◽  
Author(s):  
Jacob W. Myerson ◽  
Jacob S. Brenner ◽  
Colin F. Greineder ◽  
Vladimir R. Muzykantov

1969 ◽  
Vol 13 (3) ◽  
Author(s):  
Lars Genieser ◽  
Michael Gollin

Emerging nanotechnologies have the potential to impact a wide range of commercially important bioscience and medical applications. For example, researchers are developing nanoscale materials as diagnostic probes and targeted therapeutic delivery vehicles. By filing patents, companies can protect their intellectual property and leverage their developments over the marketplace in a way that is consistent with antitrust laws. Policies and doctrines of the US Patent and Trademark Office pertaining to nanotechnology continue to develop. Companies must be aware of challenges and strategies particular to nanotechnology in seeking patents in order to maximise the value of their innovations.


RSC Advances ◽  
2016 ◽  
Vol 6 (3) ◽  
pp. 1945-1957 ◽  
Author(s):  
Man Ma ◽  
Mingzhu Lei ◽  
Xiaoxiao Tan ◽  
Fengping Tan ◽  
Nan Li

This work was devoted to the development of a lipid-based theranostic nanoparticle able to simultaneously host conjugated polymer dots, doxorubicin (Dox) and folate acid (FA).


2011 ◽  
Vol 44 (10) ◽  
pp. 1009-1017 ◽  
Author(s):  
Sampath C. Abeylath ◽  
Srinivas Ganta ◽  
Arun K. Iyer ◽  
Mansoor Amiji

Sign in / Sign up

Export Citation Format

Share Document